Steering Committee Biographies

Robert S. Rosenson, MD, FACC, FACP, FAHA, FNLARobert S. Rosenson, MD, FACC, FACP, FAHA, FNLA
Professor of Medicine
Director of Cardiometabolic Disorders
Mount Sinai Medical Center
New York, NY


Robert S. Rosenson, MD, FACC, FACP, FAHA, FNLA, FACCP is Professor of Medicine at the Mount Sinai School of Medicine where he serves as Director of Cardiometabolic Disorders.

Dr. Rosenson earned his medical degree from Tulane University in New Orleans, Louisiana. He then served his residency in medicine at Brigham and Women’s Hospital in Boston, Massachusetts. He later completed a fellowship in cardiology at the University of Chicago that was followed by an additional year of training as a Research Associate in lipoprotein metabolism.

Dr. Rosenson has been involved in numerous grant-supported research investigations studying the effects of lipid-lowering therapy, hypoglycemic therapy, and antihypertensive agents in inflammation, thrombogenesis, and rheology. He has served as Principal Investigator on a number of NIH-funded research studies, pharmaceutical-sponsored drug trials, and multicenter studies. Recently, he served as Global Principal Investigator of the PLASMA I, PLASMA II, and FRANCIS trials. He has been an invited speaker at more than 200 national and international association meetings, grand rounds, and symposia. He has authored nearly a total of 600 journal articles, book chapters, abstracts, and electronic publications for Up To Date Medicine.


Michael Miller, MD, FACC, FAHAMichael Miller, MD, FACC, FAHA
Professor, Departments of Medicine, Epidemiology, and Public Health
University of Maryland School of Medicine
Director, Center for Preventive Cardiology
University of Maryland Medical Center
Baltimore, MD


Michael Miller, MD, FACC, FAHA serves as Professor of Medicine in the Division of Cardiology and Professor of Epidemiology and Preventive Medicine at the University of Maryland School of Medicine. In addition, he is Director, Center for Preventive Cardiology at the University of Maryland Medical System and Staff Physician at the Veterans Affairs Medical Center in Baltimore. His major research interests are disorders of lipid and lipoprotein metabolism, molecular studies of HDL cholesterol, triglycerides and the postprandial response to dietary fat, nontraditional coronary risk factors, and clinical trials to reduce atherosclerosis. Dr. Miller has participated in landmark clinical trials including AVERT, MIRACL, PROVE-IT, TNT, and COURAGE.

He is certified by the National Board of Medical Examiners and the American Board of Internal Medicine, including certifications in internal medicine, clinical lipidology, and recertification in cardiovascular disease. Dr. Miller is a Fellow of the American College of Cardiology and the American Heart Association Council on Arteriosclerosis. He is also an active Member of the American Heart Association Council on Epidemiology.

Dr. Miller has authored more than 250 original articles, book chapters and other publications. Original research articles have appeared in the BMJ, Circulation, JACC, JAMA, NEJM, PNAS, and Science. He is the co-author of The Practice of Coronary Disease Prevention, published by Williams and Wilkins (1996) and the AMA Guide to Preventing and Treating Heart Disease (2008). Dr. Miller has served on the program faculty for the American College of Cardiology Self-Assessment Program (ACCSAP) and Complex Lipid Management Self-Assessment Program that involves preparation for certification in Cardiology and Clinical Lipidology, respectively, and most recently as Chair for the AHA Scientific Statement: Triglycerides and Cardiovascular Disease. Currently, he is an Associate Editor for the journal BMC Public Health, and a member of several other editorial boards.

Dr. Miller is Past President of the American Society of Preventive Cardiology. His research has been supported by the National Institutes of Health, American Heart Association, and Veteran's Affairs Administration. He received a BA degree from Rutgers College and MD from The University of Medicine and Dentistry of New Jersey. Following a medical residency at the University of Cincinnati Hospital, he completed two fellowships at Johns Hopkins, one in lipoprotein metabolism and the second in cardiovascular disease.


Eliot A. Brinton, MD, FAHA, FNLAEliot A. Brinton, MD, FAHA, FNLA
Director, Atherometabolic Research
Utah Foundation for Biomedical Research
Salt Lake City, UT


Eliot A. Brinton, MD, FAHA, FNLA obtained his medical doctorate at the University of Utah School of Medicine, Salt Lake City, UT, and completed his internal medicine residency at Duke University, Durham, NC, then his metabolism, endocrinology and nutrition fellowship at the University of Washington, Seattle, WA. Dr. Brinton is board-certified in internal medicine and clinical lipidology and is Vice President and founding board member of the American Board of Clinical Lipidology.

Dr. Brinton has published original research in various journals, including Science, Circulation, Journal of Clinical Investigation, JAMA, and New England Journal of Medicine. He is an Editor of Lipids Online, Assistant Editor of the Journal of Obesity, and serves on the editorial boards of Journal of Clinical Lipidology, Journal of Clinical Endocrinology & Metabolism, and Clinical Lipidology. He is a fellow of the American Heart Association and Chair of Scientific Sessions Core 2 of the AHA. He is Co-director of the Cardiovascular and Metabolic Health Foundation, past President of the Pacific Lipid Association, and fellow and founding Board Member of the National Lipid Association. Currently he serves as Director of Atherometabolic Research of the Utah Foundation for Biomedical Research and Adjunct Associate Professor at the University of Utah School of Medicine.